- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Aeolus Pharmaceuticals Inc (AOLS)
Track today's live Aeolus Pharmaceuticals (AOLS) share price, performance and key data on this page with our current OTC Markets:AOLS stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Aeolus Pharmaceuticals share price on the OTC Markets exchange. Use the dropdown to switch exchange for the AOLS share price, head to our technical summary section, which provides analysis on Aeolus Pharmaceuticals share price buy/sell indicators using real-time data (or discuss the Aeolus Pharmaceuticals (AOLS) stock price today with other investors in the Aeolus Pharmaceuticals OTC share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current OTC:AOLS share price (ISIN: US00765G1094) to enhance your trading decisions with our free investment tools and resources.
What Is the Aeolus Pharmaceuticals Inc Share Price Today?
The Aeolus Pharmaceuticals share price today is 0.0001.
What Is the Stock Symbol for Aeolus Pharmaceuticals Inc
The stock symbol (or 'ticker') for Aeolus Pharmaceuticals Inc is "AOLS."
What Stock Exchange Does Aeolus Pharmaceuticals Inc Trade On?
Aeolus Pharmaceuticals Inc is listed and trades on the OTC Markets stock exchange.
Is Aeolus Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Aeolus Pharmaceuticals (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current OTC:AOLS share price (ISIN: US00765G1094) to enhance your trading decisions with our free investment tools and resources.
What Is the Aeolus Pharmaceuticals Inc Share Price Today?
The Aeolus Pharmaceuticals share price today is 0.0001.
What Is the Stock Symbol for Aeolus Pharmaceuticals Inc
The stock symbol (or 'ticker') for Aeolus Pharmaceuticals Inc is "AOLS."
What Stock Exchange Does Aeolus Pharmaceuticals Inc Trade On?
Aeolus Pharmaceuticals Inc is listed and trades on the OTC Markets stock exchange.
Is Aeolus Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Aeolus Pharmaceuticals (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
OTC Markets
Currency in USD
0.0001
0.0000(0.00%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0001
0.0001
52 wk Range
0.0001
0.0001
Trading near 52-week High
1/3
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.00010.0001
52 wk Range
0.00010.0001
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
AOLS Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell
Earnings
Latest Release
17/02/2025
EPS / Forecast
-0.01 / --
Revenue / Forecast
13K / --
Compare AOLS to Peers and Sector
Metrics to compare | AOLS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAOLSPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | −0.2x | −0.3x | |
PEG Ratio | 0.00 | −0.02 | 0.00 | |
Price/Book | 0.0x | 2.3x | 2.6x | |
Price / LTM Sales | 0.0x | 1.5x | 2.8x | |
Upside (Analyst Target) | - | 104.1% | 66.6% | |
Fair Value Upside | Unlock | 21.1% | 9.1% | Unlock |
Aeolus Pharmaceuticals, Inc., a biopharmaceutical company, develops a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious, and central nervous system diseases in the United States. The company develops a class of catalytic antioxidant compounds as medical countermeasures against nuclear, radiological, and chemical weapons, as well as for diseases and disorders of the respiratory system, central nervous system, and oncology. Its lead compound includes AEOL 10150 that has completed two Phase I clinical trials, which is developed against the pulmonary sub-syndrome of acute radiation syndrome; and for use as a medical countermeasure for exposure to chemical vesicants and nerve agents. The company is also developing AEOL 11207 for the treatment of Parkinson’s disease. Aeolus Pharmaceuticals, Inc. was founded in 1994 and is based in Mission Viejo, California.
People Also Watch
FAQ
What Is the Aeolus Pharmaceuticals (OTC Markets: AOLS) Share Price Today?
The Aeolus Pharmaceuticals stock price today is 0.0001 USD.
What Stock Exchange Does Aeolus Pharmaceuticals (AOLS) Trade On?
Aeolus Pharmaceuticals is listed and trades on the OTC Markets.
What Is the Ticker (Stock Symbol) for Aeolus Pharmaceuticals?
The stock symbol (also called a 'ticker') for Aeolus Pharmaceuticals is "AOLS."
What Is the Current Aeolus Pharmaceuticals Market Capitalisation?
As of today, Aeolus Pharmaceuticals (OTC Markets: AOLS) market cap is 152.0000 USD.
Is AOLS a Buy or Sell From a Technical Analyst Perspective?
Based on today's Aeolus Pharmaceuticals moving averages and other technical indicators, the daily buy/sell signal for AOLS stock is Sell.
How Many Times Has Aeolus Pharmaceuticals Stock Split?
Aeolus Pharmaceuticals has split 1 times. (See the AOLS stock split history page for full effective split date and price information.)
How Many Employees Does Aeolus Pharmaceuticals Have?
Aeolus Pharmaceuticals has 4 employees, based on their latest Companies House report.
What is the current trading status of Aeolus Pharmaceuticals (OTC Markets: AOLS)?
As of 31/10/2026, Aeolus Pharmaceuticals (AOLS) is trading at a share price of 0.0001 USD, with a previous close of 0.0000 USD. The stock has fluctuated within a day range of 0.0001 USD to 0.0001 USD, while its 52-week range spans from 0.0001 USD to 0.0001 USD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.